Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

It appears that much of caronavirus damage is due to cytokinetic storms among other severe immuno-responses to infection. COVID-19 damage, like SARS and MERS, is mostly centered on swelling of the alveoli which blocks oxygen and carbon dioxide transmission. If Brilacidin should work as a treatment against infections, it’s likely to be the anti-inflammatory properties rather than antiviral. Since an effective vaccine is likely 2 or more years away, simply suppressing immune response might limit damage.

Also, there are no grants available for anti influenzas that aren’t already glommed onto by Big Pharma and very well-connected startups.